Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | ADPT | RARE | ||
| Company | Provention Bio Inc | Adaptive Biotechnologies Corp | Ultragenyx Pharmaceu | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.99 | 15.19 | 23.56 | ||
| High | 25.00 | 15.59 | 24.08 | ||
| Low | 24.98 | 15.10 | 23.30 | ||
| Latest | 24.98 | 15.15 | 23.94 | ||
| Change | +0.75 | -0.04 | +0.68 | ||
| % Change | +3.10% | -0.26% | +2.92% | ||
| Volume | 9,124,100 | 2,293,200 | 1,844,000 | ||
| 20-Day Average Volume | 2,505,925 | 1,828,400 | 1,626,320 | ||
| Previous Close | 24.23 | 15.19 | 23.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 13.87 | 24.70 | ||
| 20-Day Raw Stochastic | 98.15% | 85.90% | 32.95% | ||
| 20-Day Relative Strength | 79.66 | 57.10 | 49.45 | ||
| Weighted Alpha | +19.60 | +38.08 | -11.75 | ||
| Today's Opinion | 100% Buy | 40% Sell | 24% Sell | ||
| Previous Opinion | 88% Buy | 32% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | +9.23% since 05/21/26 | +0.97% since 05/21/26 | ||
| Low | 24.20 on 04/25/23 | 13.66 on 05/26/26 | 22.74 on 05/28/26 | ||
| High | 25.00 on 04/26/23 | 15.59 on 05/29/26 | 24.12 on 05/22/26 | ||
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | +11.97% since 04/29/26 | -0.99% since 04/29/26 | ||
| Low | 23.82 on 03/27/23 | 12.50 on 05/18/26 | 22.23 on 05/19/26 | ||
| High | 25.00 on 04/26/23 | 15.59 on 05/29/26 | 27.42 on 05/11/26 | ||
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | -5.43% since 02/27/26 | +2.35% since 02/27/26 | ||
| Low | 6.59 on 03/10/23 | 12.00 on 03/12/26 | 18.29 on 03/24/26 | ||
| High | 25.00 on 04/26/23 | 16.95 on 03/04/26 | 27.42 on 05/11/26 | ||
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | -22.94% since 11/28/25 | -31.11% since 11/28/25 | ||
| Low | 6.38 on 10/28/22 | 12.00 on 03/12/26 | 18.29 on 03/24/26 | ||
| High | 25.00 on 04/26/23 | 19.80 on 02/03/26 | 39.89 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 2,424,667 | 2,357,827 | ||
| Shares Outstanding, K | 94,781 | 160,044 | 98,489 | ||
| Annual Sales | 12,900,000 | 276,980,000 | 673,000,000 | ||
| Annual Net Income | -113,570,000 | -59,500,000 | -575,000,000 | ||
| Last Quarter Sales | 10,810,000 | 70,870,000 | 136,000,000 | ||
| Last Quarter Net Income | -33,280,000 | -20,030,000 | -185,000,000 | ||
| 60-Month Beta | 2.47 | 2.16 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | -0.13 on 05/05/26 | -1.84 on 05/05/26 | ||
| Earnings Date | 05/04/23 | 08/04/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||